Ownership history in Sigma Planning Corp Β· 5 quarters on record
This page tracks every 13F SEC filing in which Sigma Planning Corp reported a position in BIOTELEMETRY INC (BEAT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Sigma Planning Corp outperformed the S&P 500 by +24.1% annually on this BEAT position. Timing score: 33% (1/3 decisions correct). Average cost basis: $2.10. Maximum drawdown during holding period: β37.8%.
π₯ Exceptional β beat the S&P 500 by 24.1% per year on this position.
3 quarters analyzed
β οΈ Poor timing β buys often preceded drops, trims preceded rallies.
1 of 3 add/trim decisions correct
Best entry: $1.25 (2025 Q2) Β· Worst: $2.40 (2025 Q4)
πͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.
4 adds Β· 1 trim. Bought during 1 of 1 down-price quarters. π Consistently bullish β fund kept accumulating this position.
βοΈ Portfolio weight has remained relatively stable β conviction maintained.
Currently 0.0% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size